Methodological challenges in measuring vaccine effectiveness using population cohorts in low resource settings.

PubWeight™: 0.80‹?›

🔗 View Article (PMC 4570930)

Published in Vaccine on July 30, 2015

Authors

C King1, J Beard2, A C Crampin3, A Costello4, C Mwansambo5, N A Cunliffe6, R S Heyderman7, N French8, N Bar-Zeev8, VacSurv Consortium

Author Affiliations

1: Institute for Global Health, University College London, 30 Guilford Street, London WC1N 1EH, United Kingdom. Electronic address: c.king@ucl.ac.uk.
2: Institute for Global Health, University College London, 30 Guilford Street, London WC1N 1EH, United Kingdom; London School of Hygiene and Tropical Medicine, London, United Kingdom.
3: London School of Hygiene and Tropical Medicine, London, United Kingdom; Karonga Prevention Study, Karonga, Malawi.
4: Institute for Global Health, University College London, 30 Guilford Street, London WC1N 1EH, United Kingdom.
5: MaiMwana Project Mchinji, Parent and Child Health Initiative, Lilongwe, Malawi; Ministry of Health, Lilongwe, Malawi.
6: Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
7: Malawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, University of Malawi, Blantyre, Malawi; Liverpool School of Tropical Medicine, Liverpool, United Kingdom; Division of Infection & Immunity, University College London, London, United Kingdom.
8: Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, University of Malawi, Blantyre, Malawi.

Articles cited by this

Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med (2000) 19.56

Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2014) 9.68

Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med (2007) 7.29

Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat Med (2002) 6.10

Field evaluation of vaccine efficacy. Bull World Health Organ (1985) 4.95

Assessing vaccine efficacy in the field. Further observations. Epidemiol Rev (1988) 3.51

Timing of children's vaccinations in 45 low-income and middle-income countries: an analysis of survey data. Lancet (2009) 3.45

Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies. Int J Epidemiol (1984) 2.96

Graphical methods for assessing violations of the proportional hazards assumption in Cox regression. Stat Med (1995) 2.83

Using verbal autopsy to measure causes of death: the comparative performance of existing methods. BMC Med (2014) 2.39

Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med (2010) 2.26

Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality. Clin Infect Dis (2014) 2.07

Verbal autopsy interpretation: a comparative analysis of the InterVA model versus physician review in determining causes of death in the Nairobi DSS. Popul Health Metr (2010) 2.04

Algorithms for verbal autopsies: a validation study in Kenyan children. Bull World Health Organ (1996) 2.01

Validation study of a verbal autopsy method for causes of childhood mortality in Namibia. J Trop Pediatr (1996) 1.86

Estimating influenza vaccine effectiveness in community-dwelling elderly patients using the instrumental variable analysis method. Arch Intern Med (2012) 1.86

Profile: the Karonga Health and Demographic Surveillance System. Int J Epidemiol (2012) 1.85

An empirical comparison of statistical tests for assessing the proportional hazards assumption of Cox's model. Stat Med (1997) 1.79

Overestimation of risk ratios by odds ratios in trials and cohort studies: alternatives to logistic regression. CMAJ (2011) 1.70

Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications. J Epidemiol Community Health (2002) 1.61

A global assessment of civil registration and vital statistics systems: monitoring data quality and progress. Lancet (2015) 1.61

Timeliness of childhood immunizations. Pediatrics (2002) 1.59

Influenza vaccination and mortality: prospective cohort study of the elderly in a large geographical area. Eur Respir J (2007) 1.54

Is vaccination coverage a good indicator of age-appropriate vaccination? A prospective study from Uganda. Vaccine (2011) 1.52

Assessment of delay in age-appropriate vaccination using survival analysis. Am J Epidemiol (2006) 1.50

Comparison of physician-certified verbal autopsy with computer-coded verbal autopsy for cause of death assignment in hospitalized patients in low- and middle-income countries: systematic review. BMC Med (2014) 1.47

Timeliness of childhood vaccinations in 31 low and middle-income countries. J Epidemiol Community Health (2011) 1.45

Spatial and socio-demographic predictors of time-to-immunization in a rural area in Kenya: Is equity attainable? Vaccine (2010) 1.43

The effectiveness of serogroup C meningococcal vaccine estimated from routine surveillance data. Vaccine (2002) 1.41

Timeliness of childhood vaccinations in Kampala Uganda: a community-based cross-sectional study. PLoS One (2012) 1.35

Control without separate controls: evaluation of vaccine safety using case-only methods. Vaccine (2004) 1.32

Vaccine epidemiology: efficacy, effectiveness, and the translational research roadmap. J Infect Dis (2010) 1.31

Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030. Vaccine (2012) 1.31

A tutorial on methods to estimating clinically and policy-meaningful measures of treatment effects in prospective observational studies: a review. Int J Biostat (2011) 1.28

Ascertainment of childhood vaccination histories in northern Malawi. Trop Med Int Health (2008) 1.27

The estimated mortality impact of vaccinations forecast to be administered during 2011-2020 in 73 countries supported by the GAVI Alliance. Vaccine (2013) 1.24

Socio-economic status by rapid appraisal is highly correlated with mortality risks in rural Africa. Trans R Soc Trop Med Hyg (2009) 1.21

Evaluating new vaccines for developing countries. Efficacy or effectiveness? JAMA (1996) 1.18

Reduction in morbidity and mortality from childhood diarrhoeal disease after species A rotavirus vaccine introduction in Latin America - a review. Mem Inst Oswaldo Cruz (2011) 1.16

Global rotavirus surveillance: determining the need and measuring the impact of rotavirus vaccines. J Infect Dis (2009) 1.14

Changes in childhood pneumonia and infant mortality rates following introduction of the 13-valent pneumococcal conjugate vaccine in Nicaragua. Pediatr Infect Dis J (2014) 1.10

The case-cohort design in outbreak investigations. Euro Surveill (2012) 1.08

Anthropometry as a predictor for mortality among Ugandan children, allowing for socio-economic variables. Eur J Clin Nutr (1994) 1.04

Relative risk regression: reliable and flexible methods for log-binomial models. Biostatistics (2011) 0.98

Vaccine effects and impact of vaccination programmes in post-licensure studies. Vaccine (2013) 0.98

Sensitivity analyses to estimate the potential impact of unmeasured confounding in causal research. Int J Epidemiol (2009) 0.96

The instrumental variable method to study self-selection mechanism: a case of influenza vaccination. Value Health (2006) 0.95

Timeliness and completeness of vaccination and risk factors for low and late vaccine uptake in young children living in rural southern Tanzania. Int Health (2013) 0.91

Observational methods in epidemiologic assessment of vaccine effectiveness. Commun Dis Intell Q Rep (2002) 0.88

Methods and challenges in measuring the impact of national pneumococcal and rotavirus vaccine introduction on morbidity and mortality in Malawi. Vaccine (2015) 0.88

Rationale and design of the CAPAMIS study: effectiveness of pneumococcal vaccination against community-acquired pneumonia, acute myocardial infarction and stroke. BMC Public Health (2010) 0.80

Determining the effectiveness of the pentavalent rotavirus vaccine against rotavirus hospitalizations and emergency department visits using two study designs. Vaccine (2013) 0.80

Efficacy of different pneumococcal conjugate vaccine schedules against pneumonia, hospitalisation, and mortality: re-analysis of a randomised trial in the Gambia. Vaccine (2014) 0.79

A potential bias in the estimation of vaccine efficacy through observational study designs. Int J Epidemiol (1989) 0.76